Introduction
Lacosamide (LCM) is a well-tolerated and effective antiepileptic drug (AED) for partial epilepsy [1, 2] . Sporadic cases of psychosis or forced normalization (FN) have been reported with some antiepileptic drugs (AEDs) [3, 4] . We report the first case of FN in a 21-year-old patient who developed psychotic symptoms on LCM coinciding with seizures resolution and EEG improvement.
Case report
Our patient is a 21-year-old right-handed gentleman who had normal birth and development until age of 7 when he was diagnosed with a craniopharyngioma complicated by hydrocephalus. His condition required surgery, radiotherapy and ventriculoperitoneal shunt placement. Subsequently he developed hypopituitarism that necessitated hormonal replacement therapy. Following an episode of refractory status epilepticus in 2007, he developed epilepsy with different seizures types: simple partial seizures with dysphasia, typical partial complex seizures, generalized tonico-clonic seizures, and very disabling nocturnal seizures with confusion. He cognitively deteriorated and had to quit school because of seizures, poor memory and concentration in addition to speech difficulties. He was admitted in 2012 for 24 h video-EEG monitoring (electrodes placed according to the 10-20 international system with inferior temporal electrodes) that revealed diffuse background slowing, with bilateral fronto-temporal independent sharp waves during wakefulness (Fig. 1 Fig. 1) showed left more than right temporal delta slowing with superimposed epileptiform discharges and rare fragments of discharges free background. In May 2014 lacosamide was titrated up to 100 mg BID. Valproate was tapered off because of excessive sleepiness. Seizures resolved completely. However, two weeks after LCM introduction family noted aggressiveness and strange behavior. Patient was having visual hallucinations. He would be talking to himself or to an imaginary friend with various gestures (movements of throwing an invisible ball, digging or tapping) in addition to inappropriate laughter and paranoid delusions towards his mother and neighbors. In September 2014, a 24 h video-EEG recording revealed a much improved wakefulness background with 8 Hz posterior dominant rhythm and left temporal delta slowing (Fig. 1) . The psychotic episodes were recorded and had no electrographic correlate.
The patient was evaluated by psychiatry and was initiated on risperidone 0.5 mg daily. LCM dose was reduced by 50 mg daily with improvement of his hallucinations and behavior within 2 weeks. In November 2014, on his follow up visit, 2 minor seizures were reported and mild occasional visual hallucinations. He was calmer and socially appropriate but at times he was noticed to smile inappropriately, or look to one side as if he was staring at someone. A follow up EEG was done and showed more frequent interictal abnormalities but overall was better compared to his baseline EEG from 2012 (Fig. 1) . He remained cognitively and psychologically stable. 
Discussion
Lacosamide, one of the newest AEDs approved in 2008 by the Food and Drug Administration has a dual mechanism of action: it enhances the slow inactivation of voltage-gated sodium channels, ending the action potential and modulates collapsin response mediator protein 2 (CRMP-2), preventing the formation of abnormal neuronal connections [1] . Rare psychiatric adverse reactions have been reported (0.03% according to Halford and Lapointe) [2] .
In 1953, Landolt was the first to describe a group of patients with poorly controlled epilepsy who had psychotic episodes associated with remission of seizures and disappearance of epileptiform activity on their EEGs. He called this phenomenon "forced normalization" (FN). He observed the increase in the number of cases of forced normalization with the introduction of succinimide drugs (eg. ethosuximide). Later this phenomenon was described with barbiturates and hydantoins [3] and several AEDs including felbamate, vigabatrin, lamotrigine, tiagabine, topiramate, zonisamide, levetiracetam and even vagus nerve stimulation [4] . We believe that FN is the most probable diagnosis in our patient since he had been psychologically stable on VNS and medical treatment for years until he developed psychosis after LCM introduction and titration. Our patient's clinical presentation Table 1 Primary and supportive diagnostic criteria for FN.
Primary criteria 1. Diagnosis of epilepsy supported by clinical history, EEG, and neuroimaging 2. Occurrence of acute/subacute behavioral disturbances 3A. Reduction in the total number of epileptiform abnormalities counted in a 60-min wake EEG recording by over 50% compared to a similar recording performed during a normal state of behavior, or, 3B. Absence of seizures for at least one week corroborated by a relative or caregiver Supportive criteria 1. Recent change (within 15 days) of the drug regimen 2. Similar behavioral disturbances in the past corroborated by a relative, caregiver, or general practitioner To make the diagnosis of FN, it is necessary to identify primary criteria 1, 2, and 3A or primary criteria 1, 2, and 3B and one supportive criterion. Abbreviations: EEG: electroencephalography; FN: forced normalization. and improved EEG findings following LCM fulfill the supportive criteria of FN such as proposed by Krishnamoorthy and Trimble in Table 1 [4] .
One of the suggested underlying mechanisms leading to the development of this condition could be the fact that epilepsy is still active but restricted sub-cortically. It has also been postulated that amygdaloid and limbic kindling may play a role in the development of this phenomenon [3] . This can apply to our patient who has evidence of bitemporal dysfunction on EEG and neuroimaging (Fig. 2) .
Additionally, we know that ion channels are expressed in the limbic regions. Knowing the established role of ion channels in the mechanism of action of various AEDs, the question arises whether FN of the EEG following lacosamide is secondary to a channel disorder [4] .
Finally, neurologists should be aware of forced normalization and consider it upon appearance of any psychotic features following LCM initiation. Further studies are needed to better elucidate the underlying pathophysiology and mechanisms of this phenomenon.
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